Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Placebo TID
DRUG
2 trials
Sponsors
Pfizer
, Vifor (International) Inc.
Conditions
Pain
Sickle Cell Disease
Phase 2
Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease
Completed
NCT04817670
Vifor (International) Inc.
Sickle Cell Disease
Start: 2021-11-18
End: 2024-03-07
Updated: 2025-02-18
Phase 3
Topical Ibuprofen for Delayed Onset Mulscle Soreness
Completed
NCT01794923
Pfizer
Pain
Start: 2013-06-13
End: 2014-03-29
Updated: 2021-09-30
Related Papers
Relationships Between Markers of Iron Status and Hematological Parameters in Patients With Sickle Cell Disease.
2024-12-03